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1. Introduction and background 
1.1 The importance of ethanol in forensic toxicology 
Ethanol has a long history as the most important substance within the field of forensic 
toxicology. In living humans, this molecule is present at low endogenous levels, but it can 
also be ingested in doses large enough to cause intoxication and criminal behaviour such as 
drunk driving.
The endogenous blood concentrations of ethanol in living subjects are too low to be 
detected by regular toxicological analyses. However, because of glucose fermentation due to 
micro-organisms, these levels might rise considerably after death, leading to endogenous 
ethanol levels that are difficult to differentiate from those caused by ingestion. 
Oxidative metabolism, which is the main pathway for ethanol, has been subject to a large 
amount of research, but non-oxidative pathways have been studied much less. This thesis 
concerns this minor ethanol metabolism, and the use of two non-oxidative products; ethyl 
glucuronide and ethyl sulphate, within forensic toxicology.
1.2 Oxidative metabolism of ethanol 
The first to present a mathematical approach to the kinetics of ethanol was Widmark in the 
1930s (1,2), but ethanol absorption and elimination had been studied even earlier (3). 
During the decades that followed, ethanol metabolism was investigated in great detail (4-8). 
Ethanol is most readily absorbed from the small intestine (9) and has a variable 
bioavailability, according to prandial state and size of the dose ingested (9-15). It can reach 
its maximum concentration (Cmax) in blood 30 minutes or less after ingestion on an empty 
stomach whereas absorption can take as long as 2 hours or more if it is administered with 
food (16-20). 
Most ethanol is metabolised in the oxidative pathways, and around 90% of the ingested dose 
is metabolised by the enzyme alcohol dehydrogenase (ADH) to acetaldehyde and further to 
acetate by the enzyme acetaldehyde dehydrogenase (ALDH) (21). ADH is also present in 
the stomach and this is considered to be one mechanism for the lower bioavailability if the 
ethanol remains in the stomach for some time before absorption (22-24). Some of the 
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ingested ethanol is also transferred to acetaldehyde by the cytochrome P450 system, mainly 
by the isoform 2E1 (25). In heavy drinkers, this enzyme is induced, which is one of the 
mechanisms for accelerated ethanol metabolism in these subjects (26). A very minor amount 
of ingested ethanol, 2-5%, is excreted directly in sweat, breath, urine or saliva (21).
1.3 Non-oxidative metabolism of ethanol; ethyl glucuronide and 
ethyl sulphate 
This work deals with the non-oxidative metabolism of ethanol. A very small amount 
(<0.2%) of the ingested ethanol undergoes phase II reactions leading to formation of the 
conjugated metabolites ethyl glucuronide (EtG) (27,28) and ethyl sulphate (EtS) (29-31). 
The formation of EtG is a result of the reaction between ethanol and glucuronic acid, 
catalysed by the enzyme uridine diphosphate glucuronosyl transferase (UGT). UGT is 
located in the endoplasmatic reticulum, mostly in the liver (32), but animal studies have 
indicated that this glucuronidation also occurs in lung tissue (33). EtS is formed after 
conjugation with sulphate (3´-phosfoadenosine 5´-phosfosulphate) catalyzed by the 
cytosolic sulphotransferase (SULT), also present in the liver and to a smaller degree in the 
pulmonary cells, according to animal studies (29). 
EtG was first described in 1901 and verified in 1952 (28) while EtS was first described in 
the literature in the 1960s (30). In the last few decades, numerous articles have been 
published describing the analyses of these metabolites. EtG and EtS have gained popularity 
and interest because of their high sensitivity and specificity as biomarkers for alcohol intake 
(34-40).
Research up to the year 2000 only concerned EtG. After this, EtS was included in the 
analytical repertoire of many laboratories and, since 2006, most studies have included both 
metabolites. In this thesis, only EtG will be mentioned in discussion of earlier research, 
while both EtG and EtS are mentioned together in discussion of the more recent studies.  
EtG and EtS have mostly been used as relapse markers for alcohol ingestion, measured in 
urine (41-61) and rarely in other matrices (62,63). Also, EtG has recently been suggested as 
a marker of chronic high alcohol intake, measured in hair (64-76). According to the research 
so far, the sensitivity and specificity exceeds that of the traditional markers for chronic high 
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alcohol intake, like the liver enzymes aspartate aminotranserase (AST), alanine 
aminotransferase (ALT) and gamma-glutamyl transferase (GGT) as well as carbohydrate-
deficient transferrin (CDT) (34,35,77-80).    
On the other hand, EtG and EtS have nearly never been mentioned in the context of forensic 
toxicology (40,81). The aim of this thesis was to study two aspects of EtG and EtS; their 
presence in post mortem cases and their blood kinetics in living subjects. The intention was 
to apply this knowledge to the use of these metabolites in forensic toxicology. To do this, 
knowledge about the serum/whole blood ratio for EtG and EtS would also be needed.
1.4 Presence of EtG and EtS post mortem 
1.4.1 Determination of post mortem ethanol origin 
Post mortem formation of ethanol is a common problem in forensic toxicology (82-88). 
Usually low levels (<0.5 g/L) are seen, and findings are not, therefore, relevant to cause of 
death, but they may be important for other reasons, such as legal and insurance related 
issues linked to car accidents. Occasionally, levels of ethanol can reach significant 
concentrations (>1.5 g/L) (89-92). There are a large number of examples, especially from 
traumatic accidents, where high ethanol concentrations are considered to be false positives. 
For example, one of the corpses from the explosion on the American battle ship USS Iowa 
had a BAC of 1.9 g/L post mortem (91). From American aircraft accidents, very likely or 
possible false positive ethanol findings were concluded in 27% and 46% of the ethanol 
positive cases, respectively (82,89,90). The findings of 1.75 g/L ethanol in the blood of 
Princess Diana’s driver in the fatal car accident has been questioned (88) as well as the 
Austrian politician, Jørg Haider’s, BAC of 1.8 g/L (93).  
Although post mortem formation of ethanol can be prevented by refrigeration of the corpse 
(83) and addition of fluoride ions to blood samples (94-97), formation still might occur in a 
significant number of cases. It has been suggested that approximately 50% of the cases with 
ethanol at a level of 0.1 g/L could be explained by endogenous formation, with lower 
frequencies at higher BACs (98). The substrate used for post mortem ethanol synthesis is 
most often glucose (99), and bacteria are responsible for the formation (97,100). For this 
reason, more severe formation would be expected after trauma, especially abdominal 
(83,101). Different criteria have been used to determine whether detected ethanol is post 
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mortem or ante mortem in origin. The case history, of course, provides important 
information, but the degree of putrefaction of the corpse (85,87,102) has also been decisive. 
The distribution of ethanol between different body fluids has been used to distinguish 
exogenous ethanol from that formed post mortem (103-105), as ethanol was thought to be 
most easily formed in blood. However, this method is not reliable, as formation in urine and 
even in vitreous humour has occurred (85,106). For more specific markers of ante mortem 
alcohol ingestion, the altered concentration ratio between the serotonin metabolites 5-
hydroxytryptophol (5-HTOL) and 5-hydroxyindole-3-acetic acid (5-HIAA) in urine has 
briefly been suggested (107-110), as this rises after ethanol ingestion (111), but its use as a 
marker of ante mortem alcohol ingestion has never been studied in detail. We wanted to 
know whether EtG could be used for this purpose.
1.4.2 Earlier studies of EtG post mortem 
Wurst et al introduced the idea of using EtG in post mortem material in 1999 (112) when 
they measured EtG in post mortem serum and urine in 3 alcoholics and 2 abstainers (113). 
They also analysed EtG in fat, liver, brain and cerebrospinal fluid in some of these subjects.  
After the start of our work, one research group published an LC-MS/MS method, modified 
from an earlier urine method which they used for post mortem blood in 12 cases (114). They 
also studied stability of EtG in liver and skeletal tissue (n=3) (115). Recently, more case 
reports where EtG was used post mortem and a stability study have been published (116-
119).
1.5 Blood kinetics of EtG and EtS in living subjects 
1.5.1 Determination of time of alcohol ingestion  
Forensic toxicologists are often asked to determine, by the use of blood ethanol 
measurements, at what time, related to an incident, a living suspect ingested alcohol. This is 
especially frequent in cases of drunk driving. A person suspected of driving under the 
influence (DUI) might claim that alcohol was ingested after the incident and that he/she had 
been abstinent for a certain period before driving (the hip flask defence) (120). One single 
ethanol result yields no information about time of ingestion, but the police often draw two 
subsequent blood samples for ethanol analysis, separated by ~30 minutes. These samples 
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are often collected ~1.5-2 h after the incident (121). The toxicologist is then able to 
determine if the suspect was in absorptive or post absorptive phase. If the person is in the 
absorptive phase (had increasing levels of ethanol in two subsequent samples), this 
strengthens his/her explanation of drinking after the incident. On the other hand, if the 
suspect is in post absorptive phase, this does not necessarily exclude the explanation, 
because maximum ethanol values might be reached as early as 30 minutes after end of 
drinking (16,18), and most blood samples are collected after this (121,122). Some 
researchers have also used of the urine/blood ratio for ethanol (17,123,124) and 
measurements of congener alcohols (125-129) to determine time of alcohol ingestion in 
such cases. We hypothesised that EtG and EtS could be used for this purpose.
1.5.2 Earlier studies of EtG and EtS blood kinetics 
Most research on EtG and EtS has been performed in urine and there are far fewer 
publications regarding blood. The analysis in serum using both GC-MS (53) and LC-MS 
(130) was published around 1995. For whole blood, there are no earlier publications we 
have been able to find. 
One single study of EtG kinetics in serum had been published prior to our work. Ten 
volunteers were administered 44-80 g of ethanol and EtG and ethanol were measured in 
serum until breath ethanol was negative, in most subjects ~8 h after drinking. Therefore, the 
terminal elimination of EtG was missed. The published study protocol was not described in 
detail and information on the type of alcohol, fasting state and food ingestion during the 
study was missing (131,132). A case report describing infusion of ethanol reaching 2.7 g/L 
in blood, including EtG concentration measurements had also been published (133). 
After our work, another kinetic study of EtG and EtS in the serum of social drinkers was 
carried out (134) and an LC/MS method for EtG in plasma (135) and an LC-MS/MS method 
for serum (136) as well as for dried blood (137) have been published. Also, EtG and EtS 
were measured simultaneously in serum with LC-MS/MS (134,138).
1.6 Use of whole blood in forensic toxicology 
Most clinical laboratories perform their analyses in serum, obtained from whole blood by 
centrifuging the sample after collection and discharge the solid layer, which represents 
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blood cells, mostly erythrocytes. The distribution of a molecule between the plasma water 
and the erythrocyte fraction of the blood will differ according to the molecule’s size, water 
solubility, degree of plasma protein binding and other factors (139,140). Forensic 
toxicology uses whole blood as a medium and the serum/whole blood ratios are therefore 
important when results are compared to those from clinical laboratories. For instance, the 
concentration of tetrahydrocannabinol has been found to be almost twice as high when 
measured in serum rather than in whole blood (141). This ratio is also well known for 
ethanol (142-145), but no such data existed on EtG and EtS.
1.7 Summary
As described in section 1.4, there were no definite criteria to determine the origin of a post 
mortem ethanol result, and a marker of ante mortem alcohol ingestion was needed. We 
wanted to investigate the use of EtG for this purpose systematically, as this idea had only 
been mentioned briefly in the literature.  
As explained in section 1.5, only limited methods existed to determine time of alcohol 
ingestion in living subjects and additional methods were needed. The use of EtG for this 
purpose had been mentioned briefly (132). We wanted to study the blood kinetics of EtG 
and EtS and hypothesised that if the blood kinetics of EtG and EtS were well known, the 
measurement of these ethanol metabolites could be helpful.
As described in section 1.6, the serum/whole blood ratio for EtG and EtS had never been 
published. If EtG and EtS were to be used in forensic toxicology, making analyses in whole 
blood, the serum/whole blood ratios would be important knowledge. 
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2. General and specific aims 
2.1 General aim 
As lined out in the introduction, the general aim of this thesis was to study the ethanol 
metabolites EtG and EtS and to apply this knowledge within forensic toxicology. 
2.2 Specific aims
On the basis of the summary of the introduction, the studies below were carried out with the 
following, more detailed, aims: 
1. To investigate the use of EtG as a marker of ante-mortem alcohol ingestion in post 
mortem cases (paper I, II and III). 
2. To study the stability of EtG, and hence the possibility of false negative or false 
positive results, in post mortem cases (paper II and III).  
3. To describe the blood kinetics of EtG in social drinkers after ingestion of low dose 
of ethanol (paper IV).
4. To describe the blood elimination of EtG and EtS in heavy drinkers after ingestion 
of large and repeated doses of ethanol (paper V). 
5. To use EtG and EtS kinetics in addition to ethanol in determining time of ethanol 
ingestion in, for instance, cases of drunken driving (paper IV and V). 
6. To determine a serum/whole blood ratio for EtG and EtS (paper VI). 
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3. Summaries of the results 
3.1 Paper I 
A study of ethyl glucuronide in post-mortem blood as a marker of ante mortem 
ingestion of alcohol 
In this study, we wanted to evaluate the sensitivity and specificity of EtG in blood as a 
marker of ante mortem alcohol ingestion. Forensic autopsy cases were divided into groups 
with and without ante mortem alcohol ingestion, according to strict inclusion criteria. The 
criteria for alcohol ingestion were: anamnestic history of alcohol ingestion before death, 
equal or higher level of ethanol in urine or vitreous humour, no trauma prior to death, no 
other putrefactive products detected (n-propanol, isopropanol) and no reported putrefaction 
of the corpse. In 93 cases (group 1a-1c) which fulfilled the criteria for ante-mortem alcohol 
ingestion, EtG was detected in blood in all cases, even when levels of ethanol were low 
(group 1c). In another 53 cases (group 2a and 2b) where there were no indications of ante 
mortem alcohol intake, EtG could not be detected in blood in a single case, including 11 
cases in which ethanol was detected and considered to be most probably formed post 
mortem (group 2b). 
Group Description n No. of cases 
with EtG 
detected
Blood EtG 
concentrations; 
Range, mg/L 
Blood EtG 
concentrations; 
Median, mg/L 
1a Alcohol ingested, high BAC 41 41 1,2 - 40 4,80 
1b Alcohol ingested, 
intermediate BAC 
40 40 0,5 - 56 3,60 
1c Alcohol ingested, low BAC 12 12 0,11 - 4,0 0,77 
2a Alcohol not ingested, no 
endogenous ethanol 
42 0 <LOQ <LOQ 
2b Alcohol not ingested, 
endogenous ethanol 
11 0 <LOQ <LOQ 
Table 1.  
Description of groups, number of cases positive for EtG, and concentration levels (median, range).  
In addition, 4 ethanol positive problem cases were presented, in which endogenous 
formation of ethanol was suspected. In three of these, no EtG was detected in blood, and this 
strengthened the assumption of post mortem ethanol formation. In the fourth case, a 17 year 
old male who died in a car accident, EtG was detected in blood in a concentration of 1.3 
mg/L, which strongly suggested ante mortem ingestion of alcohol. In conclusion, this study 
showed that ante mortem alcohol ingestion led to detection of EtG post mortem, while no 
EtG was detected if alcohol was not ingested ante mortem. 
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3.2 Paper II 
Disappearance of ethyl glucuronide during heavy putrefaction 
In paper I, we found a high sensitivity and specificity of EtG as a marker of ante mortem 
alcohol ingestion. Putrefied cases were, however, deliberately excluded from this study and 
the stability of EtG during putrefaction was unknown. The aim of paper II was to investigate 
this stability and the possibility of false negative and false positive EtG results. For this, we 
used an in vitro study. Further, we used the information from the in vitro study on real cases 
to get an impression of the practical problems of degradation or formation of EtG.  
Both degradation and formation of EtG was investigated. In the in vitro experiment, EtG 
was very unstable, and the concentrations decreased in blood samples at 30/40˚C without 
preservatives. This experiment was designed to simulate putrefaction in the corpse. On the 
other hand, EtG was stable with potassium fluoride at room temperature. This was designed 
to simulate storage in the laboratory. There was no formation of EtG either at 30/40˚C
without preservatives, or at room temperature with potassium fluoride.  
To illustrate the practical problems of degradation or formation of EtG, we used real 
autopsy samples analysed for EtG in blood. A case series of 39 post mortem ethanol 
positive cases sent routinely to the Norwegian Institute of Public Health for toxicological 
analysis were described. In 19 of these, EtG was positive in blood, with a median 
concentration of 1.6 mg/L (range 0.2-34.9). In the other 20 cases, EtG was negative in blood 
and the ethanol detected was, therefore, suspected to be of post-mortem origin. In 15 of 
these, a urine sample was available. We hypothesised that since concentrations are often 
higher in urine, there would still be traces of EtG left in this medium if post-mortem 
degradation was the reason for the negative result in blood. The results of analysis of EtG in 
urine demonstrated that 6 of the 15 cases were positive for EtG in urine, suggesting that the 
negative EtG in blood was a false negative. The other 9 showed no trace of EtG in urine, 
making the assumption of post mortem alcohol formation more reliable.  
In conclusion, this study indicated that false negative results caused by degradation could 
occur, but we found no indication of false positive results caused by formation. 
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3.3 Paper III 
In vitro formation of ethanol in autopsy samples containing fluoride ions
This is a case report describing substantial post mortem formation of ethanol despite the 
presence of preservative. In a post mortem blood sample from a diabetic patient, the 
concentration of ethanol increased from 0.4 g/L to 3.5 g/L during 8 days of normal storage 
in the laboratory (4ºC). The concentration in urine increased from 0 to 0.6 g/L. After 30 
days, there was no trace of EtG in blood or urine. This indicated that no ethanol was 
ingested before death and also showed that no EtG was formed during this period despite 
massive post mortem formation of ethanol. 
Days after 
autopsy
Ethanol
blood (g/L) 
Ethanol
urine (g/L) 
EtG blood 
(mg/L) 
EtG urine 
(mg/L) 
1 - 0 - -
2 0.4 - - -
7 2.1 - - -
10 3.5 0.6 - -
30 - - 0 0
Table 2. 
Levels of ethanol and EtG in blood and urine. 
The samples were collected using standard equipment for post mortem cases at the 
Norwegian Institute of Public Health. These contain potassium fluoride as a preservative. 
The presence of fluoride in the blood and urine samples was verified by analysis. The 
concentrations were somewhat lower than expected, but this could be caused by the 
analytical method used. Microbiological analysis of the blood sample revealed the presence 
of E. coli as well as the anaerobic bacteria Clostridium, Bacteroides and Prevotella species.
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3.4 Paper IV 
A pharmacokinetic study of ethyl glucuronide in blood and urine: Applications to 
forensic toxicology
10 healthy male volunteers ingested 0.5 g ethanol per kg body weight in a fasted state. 
Median age was 24 years (range 21-46) and median body mass index was 23.9 kg/m2 (range
20.1-28.3). They were all social drinkers with a median use of 32.5 standard drinks/month 
(range 10-60), and had abstained from alcohol during the week preceding the study, 
according to self-report. Blood and urine samples were collected for 14 h and 45-50 h after 
drinking, respectively.
Maximum concentrations (Cmax) of EtG were reached after median 4 h (range 3.5-5), a 
median of 3 h (range 2-4.5) after Cmax for ethanol. Maximum concentrations of EtG in blood 
ranged between 0.27 and 0.50 mg/L, with a median value of 0.32 mg/L. The maximum 
concentrations of ethanol in blood ranged between 0.49 and 0.78 g/L, with a median value 
of 0.58 g/L. The ethanol-to-EtG ratios in blood (ethanol in g/L, EtG in mg/L) were >1 only 
for the first median 3.5 h (range 2.5-3.5) after drinking. EtG elimination occurred with a 
median half-life of 2.2 h (range 1.7-3.1 h), and the renal clearance was 8.32 L/h (median, 
range 5.25-20.86). Total detection time was median 10 h (range 10-14) for EtG in blood.
The concentrations of EtG were always much higher in urine than in blood. The maximum 
concentrations of EtG in urine ranged between 41 and 73 mg/L, with a median value of 47 
mg/L. The total amount of EtG excreted in the urine was median 30 mg (range 21.5-39.7), 
representing 0.017% (median, range 0.013-0.022) of the ethanol given, on a molar basis. 
Total detection time was median 30 h (25-35) for EtG in urine.  
In conclusion, this study described in detail the blood kinetics of EtG and indicated that if 
alcohol ingestion occurred only a few hours before blood sampling, low and increasing 
levels of EtG would be expected. 
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3.5 Paper V 
Pharmacokinetics of ethyl glucuronide and ethyl sulphate in heavy drinkers
16 chronic heavy drinkers who stopped drinking <24 h earlier were included directly after 
admission to an alcohol withdrawal clinic. Each patient was thoroughly interviewed about 
their alcohol consumption, time of last ingestion, use of other drugs or medicines and 
relevant diseases. On admission, and repeated at varying intervals for the next 20-43 h, 3-5 
blood samples were drawn. The median age was 46 years (range 39-61) and the median 
body mass index was 26 kg/m2 (range 19-39). The median EDI the last 3 months was 172 g 
(range 60-564). All subjects, therefore, fulfilled the criteria for heavy drinking.  
The first blood sample was collected median 2.5 h after end of drinking (range 0.5-23.5).
Two patients had levels of EtG and EtS below LOQ (0.09 mg/L) in all samples, the first 
collected 19.25 and 23.5 h after cessation of drinking, respectively. Of the remaining 14 
patients, one subject, suffering from both renal and hepatic disease, showed concentrations 
of EtG and EtS substantially higher than the rest of the patients. This patient’s initial value 
of EtG was 17.9 mg/L and of EtS 5.9 mg/L, with terminal elimination half lives of 11.9 h 
for EtG and 12.5 h for EtS. Among the remaining 13 patients, the initial median values were 
0.7 g/L (range 0-3.7) for ethanol, 1.7 mg/L (range 0.1-5.9) for EtG and 0.9 mg/L (range 0.1-
1.9) for EtS. Elimination occurred with a median half-life of 3.3 h for EtG (range 2.6-4.3) 
and 3.6 h for EtS (range 2.7-5.4). Concentrations of EtG and EtS returned to below or just 
above LOQ after median 23.5 h (range 7-40).  
In conclusion, this study indicated that the blood kinetics of EtG and EtS did not differ 
considerably between social and heavy drinkers. One important exception was the subject 
suffering from kidney disease, but this condition was not necessarily related to alcohol 
abuse.
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3.6 Paper VI 
Serum/whole blood concentration ratio for ethyl glucuronide and ethyl sulphate
Serum/whole blood ratios for EtG and EtS were determined by withdrawing two blood 
samples simultaneously, one for analysis in serum and one for analysis in whole blood, from 
13 subjects at admission to an alcohol detoxification unit. EtG and EtS were analyzed in 
serum and whole blood with calibration standards and controls prepared both in serum and 
in whole blood. The median serum/whole blood value for EtG was 1.69 and the range was 
1.33-1.90. For EtS, the median serum/whole blood ratio was 1.30 and the range was 1.08-
1.47. The serum/whole blood ratio was significantly lower for EtS than for EtG (p<0.001).  
In conclusion, this study showed that concentrations of EtG and EtS were higher when 
measured in serum compared to whole blood. 
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4. Methodological considerations 
4.1 Analysis of EtG and EtS in blood and urine 
The analytical methods used to determine EtG and EtS in whole blood and urine samples in 
the papers included in this thesis were fully validated LC-MS methods comprising the use 
of deuterated internal standards for both compounds. Until 2006, we only analysed EtG. EtS 
was later included in the EtG and EtS blood and urine methods, respectively.  
The LOQ for EtG and EtS in blood was 0.058 mg/L and 0.021 mg/L, respectively and the 
LOQ for EtG and EtS in urine was 0.19 mg/L and 0.12 mg/L, respectively. These values 
were considered satisfactory for the purpose of this thesis. 
The method’s precision and accuracy was determined during the method validation and is 
included in papers I, IV, V and VI. In 2006, 131 urine samples were analysed for EtG using 
our methods at the Norwegian Institute of Public Health (NIPH). Three months later, the 
same samples were reanalysed for EtG at Karolinska University Hospital (KUH), 
Stockholm, Sweden, using a fully validated, published method (44) (table 3, unpublished 
results). The samples were collected from healthy volunteers in the drinking experiment 
(paper I) using Sterilin tubes without preservatives and stored at 4ºC. Comparing the results 
showed slightly lower values from the NIPH compared to KUH, with only 13 of 131 
samples having a NIPH/KUH ratio above 1. This strengthened the assumption that there 
was no instability of EtG during the 3 months storage. 45 of the samples were negative for 
EtG, 86 were positive. Of these, a mean NIPH/KUH ratio of 0.92 was found (SD 0.15) 
(table 3). The calibration curve differed between the two methods, including higher 
concentrations at the KUH (highest standard 1500 mg/L vs 40 mg/L). Only very few 
samples contained more EtG than 40 mg/L, but among these, the results from KUH would 
be the most reliable. The results were considered satisfactorily similar and analytical 
variations are therefore unlikely to have biased the results in this thesis. 
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Table 3. Results of the analyses of the same positive urine samples (n=86) at the Norwegian Institute of Public 
Health (NIPH) and at Karolinska University Hospital (KUH). 
No Result 
NIPH
(EtG, 
mg/L) 
Result,  
KUH 
(EtG, 
mg/L) 
Ratio 
NIPH
/KUH
No Result 
NIPH 
(EtG, 
mg/L) 
Result,  
KUH 
(EtG, 
mg/L) 
Ratio 
NIPH
/KUH
No Result 
NIPH 
(EtG, 
mg/L) 
Result,  
KUH 
(EtG, 
mg/L) 
Ratio 
NIPH
/KUH
1 4.96 6.75 0.73 30 6.98 6.74 1.04 59 36.76 44.3 0.83 
2 6.29 8.32 0.76 31 1.6 1.49 1.07 60 21.83 24.3 0.90 
3 34.89 50.9 0.69 32 0.18 0.16 1.13 61 2.49 2.77 0.90 
4 36.64 47.6 0.77 33 0.15 0.1 1.50 62 2.09 2.37 0.88 
5 52.73 72.5 0.73 34 19.16 18.4 1.00 63 1.57 1.6 0.98 
6 17.33 19 0.91 35 6.68 6.68 1.00 64 0.47 0.55 0.85 
7 3.2 3.52 0.91 36 6.84 6.94 0.99 65 4.78 5.65 0.85 
8 0.33 0.4 0.83 37 9.2 9.86 0.93 66 32.46 38.4 0.85 
9 0.31 0.46 0.67 38 21.01 23.9 0.88 67 63.13 90.2 0.70 
10 0.15 0.18 0.83 39 5.2 5 1.04 68 23.34 24.9 0.94 
11 26.56 29.7 0.89 40 2.62 2.86 0.92 69 10.67 12.2 0.87 
12 47.23 63.4 0.74 41 0.81 0.73 1.11 70 12.26 14.7 0.83 
13 24.85 29.9 0.83 42 1.42 1.71 0.83 71 2.51 2.81 0.89 
14 28.71 33.6 0.85 43 10.72 6.33 1.69 72 2.36 2.76 0.86 
15 24.17 29.1 0.83 44 10.67 13.3 0.80 73 1.16 1.31 0.89 
16 9.78 9.93 0.98 45 17.45 10.8 1.62 74 0.27 0.29 0.93 
17 6.25 6.48 0.96 46 3.52 4.05 0.87 75 0.13 0.08 1.63 
18 2.03 2.55 0.80 47 1.73 1.7 1.02 76 0.2 0.19 1.05 
19 0.68 0.79 0.86 48 0.31 0.32 0.97 77 16.03 17.4 0.92 
20 0.22 0.33 0.67 49 4.95 5.51 0.90 78 43.13 50.2 0.86 
21 0.13 0.35 0.37 50 16.34 28.2 0.58 79 6.34 6.49 0.98 
22 10.38 11.9 0.87 51 14.48 15.4 0.94 80 3.11 3.24 0.96 
23 62.81 83.9 0.75 52 33.28 39 0.85 81 2.35 2.63 0.89 
24 20.86 26.2 0.80 53 8.94 8.81 1.01 82 33.12 41.7 0.79 
25 6.96 8.23 0.84 54 1.18 1.46 0.81 83 53.85 72.3 0.74 
26 9.87 12.8 0.77 55 1.07 1.35 0.79 84 7.96 9.08 0.88 
27 2.77 2.84 0.98 56 0.17 0.19 0.89 85 17.11 18.7 0.91 
28 1 1.11 0.90 57 19.56 18.8 1.04 86 38.46 54.6 0.70 
29 0.58 0.59 0.98 58 5.49 6.01 0.91 
4.2 Post mortem presence of EtG
Paper I had methodological weaknesses. First, there was a problem with the classification of 
cases into “alcohol ingested before death” or “no alcohol ingested before death”. To be able 
to determine the sensitivity and specificity of EtG as a marker of ante mortem alcohol 
ingestion in post mortem cases, a gold standard was needed. This was complicated as there 
was no reliable criterion for post mortem alcohol formation. We, therefore, had to use all 
available criteria together to minimize the chance of misclassifying cases. The cases 
included in this paper were those in which classification of ethanol origin would be easiest, 
as all criteria for alcohol ingestion were fulfilled in group 1 (table 1, page 15), and all 
criteria for post mortem formation were fulfilled in group 2. The most problematic criterion 
was the absence of putrefaction of the corpse. We used this as a criterion for the ethanol 
detected being caused by ingestion before death, as it minimized the chance of endogenous 
formation of ethanol. A case in which the corpse was putrefied was, therefore, excluded 
from group 1. In group 1a and 1b, where blood alcohol levels were high or intermediate, this 
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was a smaller problem, but in group 1c, where BAC, and expected EtG, was low, inclusion 
of putrefied cases could have led to false negatives due to degradation of EtG. This would 
have lowered the sensitivity. Correspondingly, the group 2b, in which endogenous 
formation of ethanol was assumed because of presence of putrefaction, this could be 
misclassified and the negative EtG could be caused by degradation. On the other hand, the 
fulfilment of all the other criteria made this less probable. Paper I investigated EtG as a 
marker of ante mortem alcohol ingestion, but this study did not include complicated cases. 
Unfortunately, these complicated cases are those where the classification of ethanol as 
endogenous or exogenous is most difficult to assess, and where EtG is most needed.   
Second, the work in paper I depended on correct information from forensic pathologists on 
case history and putrefaction of the corpse as we had no way to check that information.  
Third, as the cases were included retrospectively, the samples used were up to 5 years old. 
This was necessary to obtain a sufficient number of cases. During this period, the samples 
were stored at the laboratory at -20ºC and they did contain potassium fluoride as a 
preservative. Considering the good stability of EtG during storage, this was assumed not to 
represent a large methodological problem. 
The in vitro study in paper II also had obvious weaknesses. The part of the study where 
blood samples without preservatives were incubated at 30/40ºC, aimed to simulate the 
putrefaction occurring in a corpse, before sample collection. The ideal model of this would 
be to store a corpse under different conditions and collect blood samples before and 
immediately after death and then at varying intervals. This model was considered unethical, 
and other ways to use an intact corpse, for example animal models, were considered less 
representative. We, therefore, had to use samples of post mortem blood and these might 
have behaved differently from a whole corpse, where, for example, continual degradation 
would keep adding micro-organisms to the blood.  
Also, in a better design we would have studied a number of blood aliquots drawn from the 
same corpse, to exclude analytical and other errors by verifying that the EtG in identical 
samples behaved similarly. Since the amount of peripheral blood available from a corpse 
was limited, we chose to study one large blood aliquot from each corpse instead of several 
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smaller ones. This was to prevent the withdrawal of blood for analysis from changing the 
volume significantly and altering the conditions for further degradations.
The part of paper II with blood samples containing potassium fluoride was aimed to 
simulate sample storage in the laboratory and represented fewer methodological problems. 
We used samples sent to the Norwegian Institute of Public Health routinely for toxicological 
analysis, but selected the samples directly after arrival. The stability in these samples was 
studied for the same time, 3 weeks, and storage at 4/-21ºC for a longer time period was not 
investigated.  
In papers I and II, we assumed that the samples contained fluoride when standard equipment 
was used and the presence of fluoride ions was not verified. Of course, it would have been 
better to verify this by analysis of fluoride ions in every single sample. However, the 
markedly improved stability in the samples with fluoride (paper II) made the absence of 
fluoride highly unlikely. In paper III, presence of fluoride was verified. The concentration 
(corresponding to 0.21% w/v potassium fluoride in blood and 0.25% w/v in urine) was 
lower than the recommended 1% w/v. There are two possible explanations for this: First, the 
analytical method detected only free fluoride ions and the amount bound to calcium, 
proteins and other compounds in blood could constitute a significant part. Second, the 
amount of potassium fluoride, added manually, might have been too small in these 
particular two vials. It would be easier to interpret the findings if a series of samples were 
analysed and the results compared. We realised this after we received the results from the 
first sample. The analysis of fluoride in whole blood was complicated, and unfortunately 
analysis of more samples was impossible.   
In paper III, EtG could have been analysed on arrival and on multiple occasions thereafter. 
Unfortunately, EtG was not analysed until day 30, when the case came to our attention. We 
cannot absolutely exclude the possibility that the negative EtG was caused by degradation 
but this appears unlikely, considering the low ethanol value in the first analysis as well as 
the negative result in urine.  
In all papers investigating EtG post mortem (papers I, II and III), simultaneous 
determination of EtS would have been valuable, but unfortunately, no analytical method for 
EtS existed at that time. As a control, some of the cases presented in paper II were analysed 
24
for EtS when the analytical method was fully validated, three years after the first study was 
carried out. Nine of these ethanol positive cases were negative for EtG in both blood and 
urine. We cannot totally exclude the possibility that they were false negatives caused by 
degradation in both media, but the analysis of EtS could answer this question, as recent 
research has found superior stability of EtS (119,146-148). The analyses of EtS showed that 
total loss of EtG also in urine probably did not occur, because we found that none of the 
nine urine samples negative for EtG contained EtS. The ethanol detected could therefore 
with great certainty be considered to be formed post mortem, given the negative EtG and 
EtS in both blood and urine. Also, the case described in paper III was reanalysed for EtG 
and EtS, and also in this, there were no traces of EtS in blood or urine. This further 
strengthened the assumption that no alcohol was ingested before death. There were, of 
course, methodological problems in reanalysis several years later and more studies of EtS in 
post mortem material are needed.  
4.3 Blood kinetics of EtG and EtS in living subjects 
We first performed a kinetic study in healthy, male social drinkers, without medical illness 
or use of any drugs (paper IV). A single, low dose of ethanol was administered in a fasted 
state and only water and a simple diet was ingested after this, at controlled intervals. The 
idea of performing this study in such a homogenous group of individuals and under such 
strictly controlled conditions might sound strange as the transferability to forensic material 
is uncertain. However, the aim of this study was to start a systematic investigation of EtG 
kinetics, and this required a good, controlled study as a basis. Where the results are used to 
give recommendations on determining time of alcohol ingestion, these are valid only in 
equally controlled conditions, which are almost never found in forensic toxicology.
A kinetic study of a different population with ingestion of higher doses of ethanol was 
therefore desirable, but it was then difficult to use an experimental design. The study of EtG 
kinetics in heavy drinkers (paper V) therefore had methodological weaknesses, the most 
obvious being the lack of data during ethanol absorption phase and the amount of alcohol 
ingestion based on self report. Regarding the missing data during ethanol absorption phase, 
this was regrettable, but impossible to overcome. On the other hand, 10 out of the 16 
patients were included within 3 h after the end of drinking. Efforts were made to minimize 
bias in the self declarations of consumption. A thorough interview was carried out and all 
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subjects, except one, provided concise information. Misreporting will always be a problem 
but any over or under estimating of alcohol intake would not bias the results of the study 
particularly. The information about other diseases and use of drugs or medicines was also 
based on self report because the approved protocol for the study did not allow us to collect 
information from the patient journals. Twelve of the 16 subjects used different medicinal 
drugs. The interaction with glucuronidation of ethanol for some of these might be 
hypothesised and could explain some of the larger variations in concentration levels 
compared to paper IV. We did not make any analyses to quantify the extent of these 
interactions; as such problems would also be present in forensic material.  
Also, because of limitations from the ethics committee and the clinical condition of the 
patients, only 3-5 samples were collected per patient at varying intervals. On the other hand, 
this design was, in our opinion, the best way to study a situation comparable to for instance 
drunk driving.
4.4 Serum/whole blood ratios for EtG and EtS 
For the reliability of these results, it was important that the serum and whole blood samples 
were collected at exactly the same time. We chose to use the same needle insertion and the 
sample for analysis in blood was then drawn prior to the sample for analysis in serum. As 
there were only a very few seconds between them, we considered this satisfactory.  
We had to exclude the possibility that analytical differences between the two matrices were 
the reason for different results. The whole blood calculations were performed using 
calibrations and controls in whole blood, while calibrations and controls were prepared in 
serum for the determination of concentrations in serum samples. Also, as an extra control, 
we calculated EtG and EtS concentrations in the blood and serum samples from calibrations 
and controls prepared in both types of matrices. The almost identical results in both 
situations strengthened our findings. Also, the use of deuterated internal standards for both 
compounds improved this method.  
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5. General discussion 
This thesis has explored some important, but previously unknown aspects of EtG and EtS; 
presence in post mortem cases and kinetics in blood of living subjects. We studied the 
presence in post mortem cases in order to use EtG and EtS as a marker of ante mortem 
alcohol ingestion. Our main finding was that EtG could serve as a marker of ante mortem 
alcohol ingestion, but false negative results could occur as a result of putrefaction of the 
corpse. We studied the blood kinetics in living subjects in order to find out whether EtG and 
EtS could be used to determine time of alcohol ingestion in, for example, cases of drunk 
driving. Our main finding was that high levels of EtG and EtS attenuate an explanation of 
BAC caused by very recent alcohol ingestion. We also determined the serum/whole blood 
ratios and found that concentrations of EtG and EtS were higher in serum than in whole 
blood.
5.1 Use of EtG and EtS as a marker of ante mortem alcohol 
ingestion in post mortem cases 
We showed that ethanol ingestion ante mortem did lead to the presence of EtG in post 
mortem samples, but that this EtG might be lost during putrefaction of the corpse. We also 
showed that no EtG was present in post mortem samples if alcohol was not ingested ante 
mortem, even if endogenous ethanol was formed.  
To date, no systematic studies of EtG in forensic material have been published by others, 
but stability has been studied quite thoroughly in recent years. Both our study (paper II) and 
others have documented that EtG is unstable in the presence of bacteria, both in post 
mortem material (115,119) and in clinical urine samples (146,147). The largest decrease in 
concentrations was seen in a study by Helander and Dahl, where a nearly complete loss of 
39.3 mg/L EtG occurred during 5 days at room temperature. The smallest decrease was seen 
in the early study of Schloegl et al, with ~30% decrease in EtG concentrations (n=3) during 
30 days at room temperature (115). These samples did not contain any preservatives (W. 
Weinmann, personal information). We found that refrigeration and the presence of 
preservatives made EtG stable (paper II), results that are also supported by other 
publications (146,148). It is also well documented that EtS is stable in the presence of 
bacteria, both in clinical urine samples and post mortem material (119,146,147), although a 
very recent publication showed some instability under extreme conditions, also of EtS 
27
(149). According to the available research, the stability of EtS must however be assumed to 
be much superior to that of EtG. The degradation of EtG was probably caused by ß-
glucuronidase, which occurred in 3 of 11 bacteria tested (146), and 5 of 20 bacteria tested 
(119), respectively. In both studies, ß-glucuronidase activity was found in E. coli. Since 
E.coli is such a frequent micro-organism both in urinary tract infections and in post mortem 
material (150), this is likely to constitute a significant problem. Degradation of EtS would 
occur as a result of hydrolysis by sulphatase, but this was not found in any of the bacteria 
tested and also, commercially prepared sulphatases did not hydrolyze EtS (146). We could 
not exclude the possibility that such bacteria exists (151), but the lack of sulphatase in the 
most common micro-organisms makes a practical problem of EtS degradation unlikely.  
Regarding the possibility of formation of EtG, the results are more insecure. Both our work 
(papers II and III) and other studies (115,138) showed that no EtG was formed, while 
another work (147) showed formation of EtG in clinical urine samples containing bacteria. 
No formation of EtS was found (138,147). The only sign of EtS instability was the strange 
phenomenon occurring in the kinetic study of Halter et al, where a compliant subject 
suddenly increased urine EtS, but not EtG, 42 h after ingestion (134). There was no 
explanation for this, but error in the analysis could not be excluded.
If no post mortem formation of ethanol has occurred, one could still expect a very low level 
of ethanol in these cases, since living subjects have endogenous blood ethanol 
physiologically (152-154). Considering that an expected EtG level of about 1/1000 of 
normal endogenous ethanol levels (~0.0015 g/L) would not exceed the analytical lower 
limits of detection for EtG, this would not be expected to cause false positive results. The 
negative EtG in all of the 42 post mortem cases regarding children in our study (paper I), as 
well as measurements in living abstainers (131) support this assumption.  
From the research so far, it therefore looks like EtG and EtS together are reliable markers 
for alcohol ingestion in post mortem cases. They can be determined in problem cases, but 
there are few reports of the practical use of this. A small number of case reports have been 
published in recent years. One publication described a deceased child with BAC 2.0 g/L at 
autopsy. EtG was only analysed in liver, where it was <LOD, and no EtS was analysed. The 
negative EtG could therefore be caused by degradation. On the other hand, the reason for 
the large post mortem formation of ethanol was assumed to be an intra venous infusion of 
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glucose prior to death, and there was no putrefaction of the corpse (118). Another 
publication described accidental alcohol ingestion in a child, resulting in death and post 
mortem ethanol concentrations of 4 and 5 g/L in blood and urine, respectively. In this case, 
the presence of EtG in this child’s hair (46 and 54 pg/mg) indicated chronic exposure to 
large amounts of alcohol (117). Also, in a corpse of an alcoholic exhumed 27 years after 
death, EtG and EtS were analysed. There was no information about ethanol results, but low 
levels of EtG and EtS were found in liver, kidney and blood (116). This was the only report 
of EtS post mortem, and it indicated that total degradation of EtG and EtS did not occur 
during such an extremely long time period. It is difficult to exclude the possibility that the 
presence of EtG was caused by formation after death, but the positive EtS made this less 
probable. On the other hand, studies on the fate of EtS during such extreme conditions have 
never been published before. Interestingly, the EtS/EtG ratio post mortem was much higher 
than in living subjects (61,134,155), maybe because EtS has superior stability compared to 
EtG.
In addition to possible instability, there are some relatively minor problems one must be 
aware of when using EtG and EtS to exclude post mortem alcohol formation. First, the lag 
time of EtG formation compared to alcohol could lead to false negative results. If death 
occurred immediately after alcohol ingestion, it is possible to imagine that BAC would be 
positive, but there has not been enough time to form EtG and EtS. This time gap is, 
however, short, <30 minutes (paper I), and would not normally constitute a big practical 
problem.  
Second, the longer detection time for EtG and EtS compared to ethanol could lead to false 
positive results. For example, if a person died 12 h after alcohol ingestion, alcohol could be 
completely eliminated from the body, but EtG or EtS would still be detectable in blood. If 
ethanol was detected, this might be formed post mortem, but the positive EtG and EtS 
would lead to the opposite conclusion. This difference in detection times for ethanol and 
EtG are however quite short in blood, ~10 h, according to our results (paper I and IV) and 
others (134) and the problem would be more pronounced if EtG and EtS were only analyzed 
in urine, in which this difference might be up to several days (45,61). This shows how the 
analysis in blood and urine complement each other; the risk of false negatives caused by 
instability is highest in blood and the risk of false positives from previous ethanol ingestions 
is highest in urine.
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Third, if EtG and EtS were detected together with alcohol, it is difficult to exclude the 
possibility that some of the ethanol was formed post mortem. The level of EtG and EtS 
compared to ethanol could give an indication, but this would also vary according to where 
in the time course of alcohol metabolism the subject was at time of death. Also, some of the 
ethanol detected might have diffused from the stomach into the blood stream after death 
(156,157), if death occurred too early after ingestion to allow absorption to be completed. 
According to the road traffic legislations in Norway, a measured BAC above 0.2 g/L, or an 
amount consumed that would later lead to such a BAC, defines the limit for drunk driving. 
However, in other cases, this could be a problem.     
The discussion about the sensitivity of EtG alone might sound unnecessary as most 
laboratories perform simultaneous determination of EtS. On the other hand, some 
laboratories have started to use the immunological screening, which only detects EtG 
(41,52,158). I would conclude that negative EtG results in post mortem cases in which 
endogenous formation of ethanol was suspected, obtained for instance by immunological 
screening, should be confirmed by simultaneous EtG and EtS analysis.  
5.2 Implications; Use of EtG and EtS as markers of ante mortem 
alcohol ingestion in post mortem cases 
Because of the research in papers I, II and III, as well as other progress in the field, EtG and 
EtS were routinely analyzed at the Norwegian Institute of Public Health in autopsy cases 
where post mortem formation of ethanol was suspected, according to the traditional criteria. 
From the method for EtS analysis validated in June 2007 until December 2008, 36 such 
cases were identified. In 19 of these, EtG and EtS were positive in the media analyzed 
(blood and/or urine). This strongly suggested that alcohol was ingested before death. In 16 
cases, EtG and EtS were negative in the media analyzed, strongly suggesting that the 
ethanol detected was formed post mortem (table 4).  
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Group 
according to 
EtG and EtS 
results 
Et blood, 
mean (SD) 
Et urine, 
mean (SD) 
EtG blood, 
mean (SD) 
EtS blood, 
mean (SD) 
EtG urine, 
mean (SD) 
EtS urine, 
mean (SD) 
EtG and EtS 
positive 
(n=19) 
0.15 (0.22) 0.44 (0.58) 2.5 (5.5) 1.3 (1.8) 65.2 (67.0) 17.0 (24.5) 
EtG and EtS 
negative 
(n=16) 
0.32 (0.34) 0.25 (0.24) 0 (0) 0 (0) 0 (0) 0 (0) 
Table 4. Levels of ethanol, EtG and EtS in blood and urine in 19 cases where EtG and EtS were positive as 
well as 16 cases where EtG and EtS were negative. Et=Ethanol. Ethanol in g/L, EtG and EtS in mg/L. 
In the remaining case, there was inconsistency between the results of EtG and EtS (table 5). 
In this case, EtG and EtS were both positive in urine, EtS was also positive in blood, while 
EtG was negative. One possible explanation is degradation of the probably low level of EtG 
that was present in blood. The ethanol detected was, therefore, most likely ingested, and this 
case showed the practical problem of EtG instability. 
Case nr. Ethanol 
blood       
g/L 
Ethanol
urine, 
g/L 
EtG
blood, 
mg/L 
EtS
blood, 
mg/L 
EtG
urine, 
mg/L 
EtS
urine, 
mg/L 
1 0.3 0.4 0 0.1 12.1 3.2 
Table 5. One case in which there were inconsistency between EtG and EtS results. Et=Ethanol. Ethanol in g/L, 
EtG and EtS in mg/L.  
These results show that EtG and EtS together could lead to conclusions on the origin of 
ethanol in post mortem cases. These ethanol metabolites still cannot be used as a gold 
standard, but if combining EtG and EtS, one would assume a very high sensitivity and 
specificity to detect ante mortem alcohol ingestion, according to all available knowledge. It 
is probable that many of the questionable ethanol findings in the literature, for instance from 
aviation accidents and the USS Iowa disaster, could have been answered by post mortem 
analysis of EtG and EtS. 
5.3 Blood kinetics of EtG and EtS in living subjects
To date, two studies of EtG kinetics in serum have been published, in addition to ours. 
These were controlled drinking experiments in healthy volunteers with low to moderate 
doses of ethanol ingested. We showed that in healthy volunteers after ingestion of low doses 
of ethanol, the Cmax varied relatively little between subjects (paper IV). Such relatively 
small inter individual variations were also seen in the second kinetic study (134). In 
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contrast, a much larger inter individual variation was seen in the third publication. This 
could only partly be explained by different doses, and other factors must also have 
contributed, such as age, diseases, ingestion of food and drink and others. The very high 
EtG was reached in the only female participant (131), but there is no evidence of enhanced 
glucuronidation in females compared to males, in fact the opposite is mentioned in the 
literature (159,160). The other kinetic study (134) included both men and women but after 
my own calculations based on the authors’ results (corrected for dose of ethanol), there were 
no statistically significant differences in the AUC for EtG between men and women 
(p=0.069). In our study of heavy drinkers (paper V), the four female subjects did not show 
different EtG/ethanol ratios from the male participants.  
In our kinetic study, EtG peaked median 3 h after ethanol and the level of EtG (mg/L) x 103
was lower than that of ethanol (g/L) for the first 3.5 h after ingestion. This was in 
accordance with both the other kinetic studies (131,134). In our study, EtG was eliminated 
with a terminal half life of 2.2 h. Terminal half life for EtG has only been reported in one 
other study, and the results were in accordance with ours, although they calculated half lives 
based on data from only two subjects (131). In the data from a case report infusing a high 
dose of ethanol, the EtG levels reached a plateau during the continuous supply of ethanol, 
started to decrease some hours after end of infusion and was eliminated with a somewhat 
longer half life than in to our data (133).
An interesting issue is the ratio between EtG and EtS. We studied levels of EtS in urine (not 
included in this thesis) (61). Levels of EtS in blood have been reported in one other low 
dose experiment (134) as well as in our study of heavy drinkers (paper V). Both our studies 
and other studies of EtG and EtS in blood and urine indicated that levels of EtG were higher 
than the corresponding levels of EtS (61,155), also when corrected for different molecular 
weight, with molar EtG/EtS ratios reported as 1.7. Only one study in urine showed higher 
concentrations of EtS than EtG (161), and similar molar concentrations of EtG and EtS were 
seen in serum in the kinetic study by the same group (134), although the AUC was higher 
for EtG. The reason for the higher EtS concentrations is unknown, but direct ingestion of 
EtS could be hypothesised. Also, the measurement in serum would be expected to cause 
even lower concentrations for EtS compared to EtG, according to our results in paper VI. It 
is documented that certain alcoholic wines contain EtS (up to 40 mg/L) and to a much 
smaller extent EtG (up to 4 mg/L) (162), as fungi and yeasts can carry out phase two 
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reactions (163) during the production process. If such beverages were ingested in the 
experiment, this could lead to higher concentrations of EtS. On the other hand, there is no 
knowledge about the bioavailability of EtG and EtS. The fact that EtG and especially EtS 
could be formed from ethanol in alcoholic beverages could theoretically strengthen the idea 
that EtG and EtS could form in biological matrices. On the other hand, there is quite good 
evidence suggesting that no formation of EtS occurs. The amount of micro bacteria present 
during the production of alcoholic beverages is probably much higher, and the species could 
be different from that present in biological matrices.  
We calculated that 0.013-0.022% (n=10) of the ingested dose of ethanol was excreted in 
urine as EtG (paper IV). This was in accordance with an earlier study after the same dose of 
ethanol (n=6) (49), but lower than another study at a lower dose (n=7) (55). We further 
showed that somewhat less of the ingested ethanol was excreted as EtS (61) (not included in 
this thesis). The amount excreted as EtG was significantly higher than EtS (p<0.001). This 
was lower than in an earlier single case which reported results for EtS (161). However, this 
was the only study to show higher values of EtS than EtG in urine.
Another interesting question is whether a different proportion of the ingested ethanol is 
converted to EtG at higher doses. An early, preclinical study indicated that more ethanol 
was converted to EtG at higher doses in rabbits (28). The method of administration was not 
reported. In humans, this should be studied by administering different doses and collecting 
all urine voided until the end of EtG elimination. One study administered 3-25 g of ethanol 
to 4 subjects, and showed a dose-response relationship, with a larger % of the ethanol 
excreted as EtG at higher doses (56). When comparing this to our results (paper IV) and 
those by Dahl et al (49), where larger doses were ingested, this further strengthens the 
picture of a dose-response curve. In our study of heavy drinkers (paper V), where very large 
doses were ingested, the EtG/ethanol ratios were higher, but this could also be caused by 
accumulation of conjugated metabolites over a longer time period. Although the terminal 
half life for EtG and EtS is only ~3 hours, accumulation could still occur, as some subjects 
ingest alcohol in frequent doses (paper V). All these results could be explained by saturation 
of the oxidative ethanol metabolism, driving more ethanol in the non-oxidative direction. 
ADH is saturated at approximately 0.2 g/L ethanol, and this is in accordance with the 
findings of glucuronidation, which showed increasing activity after ingestion of doses 
higher than 0.15 g/kg, resulting in blood alcohol concentrations around 0.2 g/L (56). An 
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alternative explanation is the lower bioavailability of ethanol when ingested in low doses. 
The pre-systemic gastric metabolism of ethanol is more pronounced after ingestion of low 
doses, and a smaller percentage of the ingested ethanol would be available for 
glucuronidation. The possibility can, therefore, not be excluded that the same amount of 
available ethanol is metabolised to EtG and EtS at different doses, even if concentrations of 
these metabolites were higher after higher doses ingested orally. To answer this question, 
intra venous ethanol must be administered. Also, our post mortem material (paper I) and 
results from urines collected from drunk drivers (48) showed the opposite results with a 
lower ratio between EtG and ethanol at higher BACs. These results were less reliable as 
they were not controlled experiments, but only randomly collected single samples from each 
subject. I suggest that these results were caused by the fact that lower BACs occur mainly in 
the later phase of ethanol metabolism, where the levels of EtG have reached higher 
concentrations. The explanation was, therefore, not necessarily a limited capacity of the 
glucuronidation process, as we originally suggested in paper I. Also, all kinetic studies 
showed a tendency towards higher levels of EtG in blood or urine at higher BAC. The 
research so far could therefore suggest that there is no saturation of the enzymes responsible 
for EtG formation, at least in the ethanol doses tested, and that the non oxidative metabolism 
possibly increases as the oxidative pathways are saturated.
There are no reports in the literature of extra renal excretion of EtG or EtS, but this cannot 
be excluded theoretically, considering that the glucuronides of morphine, for example, are 
partly excreted in bile and eventually in faeces (164,165). In paper IV, we calculated a renal 
clearance for EtG, based on the AUC in blood and the urinary excretion during the same 
time interval. We then calculated a total clearance, by using a calculated Vd for EtG. That 
calculation was inaccurate and only gave an indication, as it was based on a theoretically 
calculated C0, representing the ingested “dose” of EtG. However, a much higher value for 
total clearance compared to renal clearance would indicate extra renal excretion. Our values 
for total clearance were in the same order of magnitude as the renal clearance, actually 
slightly higher, indicating inaccurate calculations, but probably no significant extra renal 
excretion. As these aspects were not studied by others, we can not relate our results to other 
research.
The up or down regulation of UGT and SULT during chronic heavy alcohol use is another 
interesting question. Preclinical studies have indicated both increased (166-168) and 
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unchanged (168,169) glucuronidation and sulphatation after chronic ethanol feeding. Also, 
decreased activity was shown (170), but this was due to reduced availability of required co-
factors, not lower enzyme activity. The results are therefore quite confusing, and clinical 
evidence is missing. Our kinetic study of heavy drinkers (paper V), which is the only 
publication on a sample from this population, gave a picture of the difference in kinetics 
between social and heavy drinkers. Our interesting finding was that the terminal half lives, 
with the exception of one subject, were comparable in the two populations, at 2-3 hours. 
This may indicate that there is no up-regulation of enzyme activity, but it also described the 
excretion of EtG and EtS. The concentrations of EtG and EtS returned to a low level around 
24 h after end of dinking. This was in accordance with studies of EtG in plasma in patients 
with alcohol use disorders, where EtG was not detected median 20 h after end of drinking 
(136). One single subject in our study of heavy drinkers had kinetics of EtG and EtS which 
differed completely from the rest of the material with four times longer half lives. He 
suffered from kidney disease, which could cause delayed excretion and therefore 
considerably lengthen the half lives of the conjugated ethanol metabolites. This effect of 
kidney disease is described for excretion of other glucuronides, for example, those of 
morphine (171-173). This individual also suffered from hepatic disease (hepatitis B and C), 
but this should not, in theory, cause prolonged half lives. Also, his ethanol metabolism was 
normal, and the two other patients suffering from hepatitis had normal kinetics of EtG and 
EtS. He still showed a high level of EtG and EtS 31 h after end of drinking and if using his 
half life of 12 h, the calculated detection times for EtG and EtS in blood would be about 100 
h after end of drinking. One previous study found EtG in plasma in 4 of 81 patients >48 h 
after self reported end of drinking. This was interpreted as misreporting, but could also 
represent subjects with delayed excretion caused by renal failure or other factors (135). 
Also, in an abstract from 1995, it was reported that half lives for EtG in heavy drinkers 
ranged between 2 and 12 h and that “some subjects showed longer half lives than social 
drinkers” (174). No further information about the study was available. 
The maximum levels of EtG and EtS in heavy drinkers were higher than in social drinkers, 
but this was caused by higher doses ingested and accumulation of EtG and EtS, not 
necessarily by up regulation of the enzymes. To answer the question of effect of chronic 
heavy alcohol use on UGT and SULT satisfactorily would therefore require different study 
designs from ours, with measurements of total amount excreted both in social and heavy 
drinkers in controlled experiments.       
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I conclude that the kinetics of EtG and EtS are comparable in social and heavy drinkers. We 
found no evidence that the effect on the liver frequently seen after heavy alcohol use would 
affect the kinetics of EtG and EtS. We showed that the presence of renal disease probably 
causes substantially prolonged half lives. This clinical status is not necessarily related to 
heavy alcohol use. We can not exclude other factors that may also result in delayed renal 
excretion, for example, interactions with drugs like probenecid. This drug inhibits the 
excretion of substances which are secreted in the kidney by tubular secretion (175), which is 
the well known excretion route for both glucuronic acid and sulphate conjugates (176). 
Diseases affecting other organs would be less likely to affect the half lives of EtG and EtS 
given that these conjugated ethanol metabolites are almost solely excreted renally.  
5.4 Use of EtG and EtS to determine time of alcohol ingestion 
As described in the introduction (section 1.5), there were only limited methods to determine 
time of alcohol ingestion in a living subject and one aim of this thesis was to use 
measurements of EtG and EtS in blood samples for this purpose. 
Our controlled low dose kinetic study (paper IV) as well as two other kinetic EtG studies 
(131,134), indicated that concentrations of EtG could provide information about time of 
alcohol ingestion. According to all three studies, EtG was formed with a delay compared to 
ethanol and EtG levels should be increasing in two subsequent samples if alcohol was 
ingested in the 2-4 hours before sample collection. Also, if ingestion was within the 2-3 h 
before sampling, the levels of EtG x 103 should be below that of ethanol (mg/L and g/L, 
respectively). 
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Figure 1. The time after ingestion of ethanol determines the level of EtG (brown line) compared to ethanol 
(green line). 
This would only be valid if ethanol was ingested in the same pattern as in the experiments; 
one single, low to moderate dose ingested by a social drinker, otherwise healthy. This 
scenario is hardly ever the case in drunk driving. If high or decreasing levels of EtG are 
found, it could then be concluded that those levels did not originate from a single, recent 
ingestion, and alcohol was also drunk before driving. The question is how much earlier 
could drinking occur that would lead to such high levels of EtG? Could an individual drink 
the night before and still have high EtG concentrations even if the alcohol was eliminated a 
long time ago? The explanation of drinking after driving as the only source of impairment 
could therefore be correct, but the EtG levels had no connection with that ingestion. 
That was what we showed in our study of heavy drinkers (paper V). The results indicated 
that after a period of very heavy drinking, the terminal half lives for EtG and EtS were ~3 h 
and the levels of EtG and EtS in blood would return to below LOQ after approximately 24 
h, ~10 h after ethanol. High levels of EtG and EtS could therefore not be explained by 
drinking the day before blood sampling.  
If a suspect claims to have drunk alcohol after an incident, it would be a relatively quick 
ingestion of a single dose of alcohol. This situation resembles that of the controlled, kinetic 
studies of social drinkers. As we also showed that kinetics in heavy drinkers did not 
significantly differ from the social drinkers, the data between the populations could be 
transferrable.
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We could therefore suggest that high and/or decreasing EtG and EtS levels weakens an 
explanation of recent drinking, while low and/or increasing levels of EtG and EtS 
strengthens such an explanation.
We must not forget that there was one important exception in our study of heavy drinkers. 
The patient suffering from kidney disease had considerably prolonged half lives for these 
ethanol metabolites. Such a condition must therefore be excluded before using 
measurements of EtG and EtS in the way described above. An indication of the subject’s 
individual half life for EtG and EtS might be obtained from calculations if two subsequent 
blood samples show decreasing values.  
It must also be noted that low levels of EtG would not be a definite proof of recent drinking, 
as some subjects show very minor glucuronidation of ethanol. This was the case for one of 
the 51 subjects studied in kinetic experiments (131). This was not surprising, considering 
the high prevalence of Gilbert’s disease. This condition is a hereditary defect in the 
isoenzyme 1A1 of the UGT family, the enzyme predominantly responsible for ethanol 
glucuronidation (32). The disease is present in 5-10% of the population and glucuronidation 
in these subjects is approximately 30% of normal (177-179). The levels of EtG could 
therefore be low, but not necessarily absent. There are also more seldom and severe 
conditions affecting glucuronidation, such as the very rare Crigler-Najjar syndrome type 1, 
which shows no UGT1A1 expression at all (180).
There are no well known conditions affecting the sulphatation of substances in an equivalent 
way, but one of the subjects in our kinetic studies showed no EtS in serum, although he had 
EtS in urine (134). The reason for this was unknown. However, conditions affecting both 
systems are less likely, and this shows the advantage of testing for both these ethanol 
metabolites. If a suspect has a high BAC e.g. 2 h after the incidence and 1 h after alleged 
time of drinking, low or increasing levels of both EtG and EtS very much support this 
explanation.
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5.5 Implications; use of EtG and EtS to determine time of alcohol 
ingestion
As described above, measurements of EtG and EtS could be very helpful in determining the 
time of ethanol ingestion, although they give no definite proof. As a result of the research in 
papers IV and V, EtG was analysed in selected routine cases of drunk driving at the 
Norwegian Institute of Public Health. One such case is described below and shown in figure 
2 as an example:
A 50 year old male was involved in a car accident at 2.30 p.m. Blood samples collected at 
5.15 p.m. and 5.45 p.m showed ethanol concentrations of 2.3 and 2.2 g/L, respectively. The 
suspect explained that he had consumed 150 g alcohol after the incident, at 3.00 p.m. Before 
this he had been abstinent for about 20 h. The level of EtG would therefore be expected to 
be very low. In fact, very high levels of EtG were found. According to the results from 
papers IV and V, this could not be explained by a single ingestion 2.5 h earlier at 3pm or by 
consumption more than 20 hours earlier. High doses of alcohol must therefore have been 
consumed during a longer, continuous interval before sampling.   
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Figure 2. 
Concentrations of ethanol and EtG according to measured values (largest points, unfilled), otherwise 
simulated. From information about a single ingestion of 150 of ethanol 2.25 and 2.75 h before sample 
collection, values in the area of the “EtG expected” should be seen. The measured values of EtG were much 
higher than expected and therefore weaken the explanation given. Ethanol in g/L, EtG in mg/L.        
5.6 Serum/whole blood ratios 
Concentrations of both EtG and EtS were higher when measured in serum than in whole 
blood, according to our results in paper VI. This difference was more pronounced for EtG 
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than for EtS. There were and still are no other publications addressing this question. The 
chemical properties of these molecules were not investigated, but from the structural 
formula, there are some qualities that could explain our findings. First, they are much larger 
than their parent molecule ethanol and would be expected to have problems penetrating the 
cell membrane to enter the red blood cells. The smaller size of EtS compared to EtG could 
possibly explain the lower serum/whole blood ratio for EtS. Second, their water solubility 
and corresponding lack of lipofilicity makes penetration into red blood cells difficult.
Bindings to serum proteins for EtG and EtS are not reported in the literature. We cannot, 
therefore, exclude this as a possibility, and it could explain some of the higher values in 
serum than in whole blood.   
The difference between serum and whole blood concentrations of EtG and EtS could be of 
practical importance. Although there are both inter and intra individual variations in EtG 
and EtS levels obtained from ingestion of a certain ethanol dose, a 70% higher result when 
measuring EtG in serum than in whole blood is important. One could imagine a couple of 
examples. First, when comparing publications where similar ethanol levels lead to different 
EtG and EtS results, the serum/whole blood ratio should be considered as one possible 
explanation. Second, if wider use of EtG and EtS is evolved, a serum sample for clinical 
analysis and a whole blood sample for forensic analysis could be obtained from the same 
patient within the same period and analysed for EtG and EtS. This currently happens for 
ethanol. It would then be relevant to have a simple explanation for different results.
In conclusion, the comparison between serum and whole blood concentrations could be 
necessary in different situations, and this thesis revealed the expected difference in results 
between these two media.  
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6. Conclusions
1. EtG can be used as a marker of ante mortem alcohol ingestion in post mortem cases.  
2. Due to stability problems, false negative results could occur and a negative blood 
EtG result in heavily putrefied cases should be interpreted with caution. Analysis of 
another medium might raise the sensitivity. We found no formation of EtG during 
putrefaction. There appears, therefore, to be a low chance of false positive results. 
3. In social drinkers after a low dose of ethanol, EtG reaches its Cmax 2-3 h after Cmax
for ethanol and is eliminated with a terminal half life of 2-3 h. The total amount of 
EtG excreted in the urine was median 0.017% of the ingested ethanol.
4. The elimination of EtG and EtS occurs at the same rate in heavy drinkers after 
ingestion of high and repeated doses of ethanol with a terminal half life in blood of 
~3 h for EtG and ~3.5 h for EtS. One important exception is the presence of kidney 
disease.
5. If ingestion of alcohol took place ~3 h or less before blood sampling, levels of EtG 
should be below that of ethanol (ethanol in g/L, EtG in mg/L). If two subsequent 
blood samples are drawn, increasing values of EtG should be seen up to ~3 h after 
intake. If high and/or decreasing levels of EtG are seen, this supports an explanation 
of recent drinking. Drinking much earlier, eg, the night before is less likely to 
explain high levels of EtG.
a. The concentrations of EtG and EtS are higher in serum than in blood with 
serum/whole blood ratios of ~1.7 for EtG and 1.3 for EtS. 
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